Treatment of factor vii deficiency with recombinant factor vila

Pathophysiology of Haemostasis and Thrombosis

Volumn 26, Issue , 1996, Pages 155-158

  Bauer, Keneth A ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Bleeding disorder; Factor VII deficiency; Factor VIla

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

BLEEDING DISORDER; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CASE REPORT; CONFERENCE PAPER; HUMAN; PRIORITY JOURNAL;

FACTOR VII DEFICIENCY; FACTOR VIIA; HEMORRHAGE; HUMANS; RECOMBINANT PROTEINS;

EID: 0029865789     PISSN: 14248832     EISSN: 14248840     Source Type: Journal    
DOI: 10.1159/000217259     Document Type: Article

References (22)

1. Hagen FS, Gray CL, O’Hara P, Grant FJ, Saari GC, Woodbury RG, Han CE, Inslcy M, Kisicl W, Karachi K, Davie EW: Characterization of a cDNA coding for human factor VII. Proc Natl Acad Sci USA 1986; 83:2412-2416.
2. Fair DS: Quantitation of factor VII in the plasma of normal and warfarin-treated individuals by radioimmunoassay. Blood 1983:62:784-791.
3. Ostcrud B, Rapaport SI: Activation of factor IX by the reaction product of tissue factor and factor VII: Additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 1977;74:5260-5264.
4. Bauer KA, Kass BL, ten Cate H, Hawiger JJ, Rosenberg RD: Factor IX is activated in vivo by the tissue factor mechanism. Blood 1990;76: 731-736.
5. Radcliffe R, Nemerson Y: The activation and control of factor VII by activated factor X and thrombin. Isolation and characterization of a single chain form of factor VII. J Biol Chem 1975;250:388-395.
6. Kisiel W, Fujikawa K, Davie EW: Activation of bovine factor VII (proconvertin) by factor Xlla (activated Hagcman factor). Biochemistry 1977;16:4189-4194.
7. Radcliffe R, Bagdasarian A, Colman R, Nemerson Y: Activation of bovine factor VII by Hagcman factor fragments. Blood 1977;50:611-617.
8. Seligsohn U, Osterud B, Brown SF, Griffin JH. Rapaport SI: Activation of human factor VII in plasma and in purified systems. Roles of activated factor IX, kallikrein. and activated factor XII. J Clin Invest 1979; 64:1056-1065.
9. Nakagaki T, Foster DC, Berkner KL, Kisiel W: Initiation of the extrinsic pathway of blood coagulation: Evidence for the tissue factor dependent autoactivation of human coagulation factor VII. Biochemistry 1991;30:10819-10824.
10. Pedersen A. Lund-Hanscn T, Bis-gaard-Frantzen H, Olsen F, Petersen LC: Autoactivation of human recombinant coagulation factor VII. Biochemistry 1989:28:9331-9336.
11. Ragni MV, Lewis JH, Spero JA, Ha-siba U: Factor VII deficiency. Am J Hematol 1981;10:79-88.
12. Triplett DA, Brandt JT, McGann Batard MA, Schaeffer Dixon JL, Fair DS: Hereditary factor VII deficiency: Heterogeneity defined by combined functional and immunochemical analysis. Blood 1985:66: 1284-1287.
13. Boyer C, Wolf M, Rothschild C, Mi-gaud M, Amiral J, Mannucci PM, Meyer D, Larrieu MJ: An enzyme immunoassay (ELISA) for the quantitation of human factor VII. Thromb Haemost 1986;56:250-255.
14. Girolami A, Falezza G, Patrassi G, Stcnico M, Vettore L: Factor VII Verona coagulation disorder Double heterozygosis with an abnormal factor VII and heterozygous factor-VII deficiency. Blood 1977,50:603.
15. Girolami A. Fabris F, Dal Bo Zanon R, Ghiotto G. Burul A: Factor VII Padua: A coagulation disorder due to an abnormal factor VII with a peculiar activation pattern. J Lab Clin Med 1978;91:387-395.
16. Girolami A, Cottarozzi G, Dal Bo Zanon R, Celia G, Toffanin F: Factor VII Padua2: Another factor VII abnormality with defective ox brain thromboplastin activation and a complex hereditary pattern. Blood 1979;54:46-53.
17. Tuddenham EGD. Pemberton S, Cooper DN: Inherited factor VII deficiency: Genetics and molecular pathology. Thromb Haemost 1995;74: 313-321.
18. Green F, Kcllcher C, Wilkes H, Temple A, Meade T. Humphries S: A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arteriosclerosis Thromb 1991; 11:540-546.
19. Humphries SE, Lane A, Dawson S. Green FR: The study of gene-environment interactions that influence thrombosis and fibrinolysis. Genetic variation at the loci for factor VII and plasminogen activator inhibitor-1. Arch Pathol Lab Med 1992; 116:1322-1329.
20. Arbini AA, Bodkin D, Lopaciuk S, Bauer KA: Molecular analysis of Polish patients with factor VII deficiency. Blood 1995;84:2214-2220.
21. Bech RM, Nicolaiscn EM, Andersen PM. Glazer S, Hcdner U: Recombinant factor Vila for the treatment of congenital factor VII deficient patients (abstract). Thromb Haemost 1995;73:983.
22. Bauer KA. Mannucci PM, Gringeri A, Tradati F. Barzegar S. Kass BL, ten Cate H, Kcstin AS. Brettlcr DB, Rosenberg RD: Factor IXa-factor Villa cell surface complex does not contribute to the basal activation of the coagulation mechanism in vivo. Blood 1992:79:2039-2047.